News for 'Lancet'

India will beat China to become world's largest employer

India will beat China to become world's largest employer

Rediff.com22 Jul 2020

A report published in British journal The Lancet reckons India's working population will surpass China's in the mid-2020s.

Pfizer jab produces less antibodies against Delta variant: Study

Pfizer jab produces less antibodies against Delta variant: Study

Rediff.com4 Jun 2021

The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.

India to produce 850mn Sputnik doses annually: RDIF

India to produce 850mn Sputnik doses annually: RDIF

Rediff.com13 Apr 2021

As per RDIF, Sputnik V has a number of key advantages, including that there are no strong allergies caused by Sputnik V.

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Rediff.com16 Sep 2020

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India, RDIF and Dr Reddy's said in a joint statement.

Pandemic weight gain increased type-2 diabetes risk: UK study

Pandemic weight gain increased type-2 diabetes risk: UK study

Rediff.com4 Sep 2021

The NHS estimates that weight gain of one kg, or 2.2 pounds, can increase someone's risk of diabetes by around 8 per cent.

Air pollution spreads Covid faster, govt officials tell Parl panel

Air pollution spreads Covid faster, govt officials tell Parl panel

Rediff.com6 Nov 2020

Air pollution may lead to a faster spread of Covid-19 infection as it causes coughing and sneezing, government officials told a parliamentary panel on Friday, according to sources.

Air pollution: India, China worst sufferers

Air pollution: India, China worst sufferers

Rediff.com1 Jul 2015

The industrialised world must work fast.

5% cancer cases in India last yr linked to drinking: Study

5% cancer cases in India last yr linked to drinking: Study

Rediff.com15 Jul 2021

Globally, the researchers found that more than 7,40,000 or four per cent of new cancer cases in 2020 may be attributed to alcohol drinking.

New bird flu virus in China becoming drug-resistant

New bird flu virus in China becoming drug-resistant

Rediff.com29 May 2013

The deadly new strain of bird flu that has killed 36 people in China has developed resistance to antiviral drugs in some patients, scientists say.

COVID-19 vaccine by Oct-Nov: Serum Institute CEO

COVID-19 vaccine by Oct-Nov: Serum Institute CEO

Rediff.com22 Jul 2020

Poonawalla, during an interaction with Odisha Chief Minister Naveen Patnaik through a video conference, expressed optimism that the COVID-19 vaccine could be ready by October-November this year and the next phase of the trial can start in mid-August in India. According to a press note released by the CMO, Poonawalla has informed that the Oxford University vaccine has shown promising results in the first phase trial.

50% of all pregnancies in India unintended

50% of all pregnancies in India unintended

Rediff.com21 Dec 2017

According to a Lancet study an estimated 15.6 million abortions took place in India in 2015, of which about half of the pregnancies were unintended.

Focus on double vaccination first: Experts amid calls for booster

Focus on double vaccination first: Experts amid calls for booster

Rediff.com4 Dec 2021

'Scientific data has proven that masks can reduce COVID-91 transmission by 53 per cent...A booster dose of vaccine, even if it works, is just a temporary fix'

WHO stops trial of anti-malarial drug for COVID-19 treatment

WHO stops trial of anti-malarial drug for COVID-19 treatment

Rediff.com26 May 2020

WHO director-general Tedros Adhanom Ghebreyesus said that in view of a paper published last week in the Lancet medical journal, that showed people taking hydroxychloroquine were at higher risk of death and heart problems than those that were not.

COVID-19 reinfection 'very rare': ICMR DG

COVID-19 reinfection 'very rare': ICMR DG

Rediff.com15 Sep 2020

The remarks come amid suspected cases of COVID-19 reinfection being reported from abroad and from Indian states like Telangana, Karnataka, Gujarat, Punjab and Maharashtra.

Oxford COVID-19 vaccine hopes rise with strong trial results

Oxford COVID-19 vaccine hopes rise with strong trial results

Rediff.com16 Jul 2020

Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and 'killer T-cells', a senior source from the trial was quoted by The Daily Telegraph as saying.

India's silent killer: Time to wake up

India's silent killer: Time to wake up

Rediff.com4 Jun 2012

It has always been perceived that cancer is generally restricted to the more affluent class in comparison with the poorer people. This is a myth and a recent report in Lancet has busted it. Sriram Balasubramanian reports.

'Strong evidence' COVID-19 predominantly spreads through air: Study

'Strong evidence' COVID-19 predominantly spreads through air: Study

Rediff.com16 Apr 2021

The researchers noted that transmission rates of SARS-CoV-2 are much higher indoors than outdoors, and transmission is greatly reduced by indoor ventilation.

Physical inactivity kills 5.3 mn people a year: Study

Physical inactivity kills 5.3 mn people a year: Study

Rediff.com18 Jul 2012

Physical inactivity causes about six to 10 per cent of major non-communicable diseases, including coronary heart disease and type 2 diabetes, and kills around 5.3 million people a year, a new study has claimed.

Govt expects speedy launch of single-dose Sputnik Light vaccine

Govt expects speedy launch of single-dose Sputnik Light vaccine

Rediff.com27 May 2021

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.

India readies 5 sites for final phase of trials of Oxford COVID vaccine

India readies 5 sites for final phase of trials of Oxford COVID vaccine

Rediff.com28 Jul 2020

The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready. Trials results for the first two phases were published earlier this month.

Central Vista: Why is Modi in such a hurry?

Central Vista: Why is Modi in such a hurry?

Rediff.com14 May 2021

'A setback in UP will be nothing short of a political disaster on the eve of the 2024 general election.' 'Will it mean that Modi will be able to stay in his new house only for a year after it becomes ready?' asks Amulya Ganguli.

Children more resilient against COVID-19: Study

Children more resilient against COVID-19: Study

Rediff.com28 Jun 2020

The researchers said 5.6 per cent of the children assessed in the studies suffered from co-infections, such as flu, on top of COVID-19, and a little more than 3 per cent were admitted to intensive care units.

Malaria kills 200,000 people in India every year!

Malaria kills 200,000 people in India every year!

Rediff.com23 Oct 2010

Malaria kills more than 200,000 people in India every year, nearly 13 times higher than a 'misleadingly low' World Health Organisation estimate, a new study has claimed, but the United Nations body disputed the finding.

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Rediff.com19 Aug 2020

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.

'Superbug resistant to antibiotics could spread'

'Superbug resistant to antibiotics could spread'

Rediff.com11 Aug 2010

A team of experts has, in fact, tracked the enzyme in Britain, India, Pakistan and Bangladesh and believes it to be more widespread than first thought. It is said to be resistant even to a class of antibiotics known as carbapenems, which are reserved for use in emergencies and used when bacteria are found to be resistant to more commonly prescribed antibiotics.

Delhi CM asks people not to panic over 'superbug'

Delhi CM asks people not to panic over 'superbug'

Rediff.com11 Apr 2011

Chief Minister Sheila Dikshit on Monday appealed to people in the city not to panic in the wake of reports that a drug resistant bacteria had been found in Delhi's public water supply. The Delhi Jal Board had rejected the findings of international scientific journal Lancet, she said. "The Delhi Jal Board has very categorically said that this is not the case. I am in touch with the CEO and he said that it is not so. So please don't spread panic," she said.

Sputnik vaccine shows 92% efficacy

Sputnik vaccine shows 92% efficacy

Rediff.com27 Nov 2021

'A good 30 per cent of people will still get infected after getting the Covishield vaccine.'

Russia's COVID vaccine shows over 91% efficacy in phase 3 trial

Russia's COVID vaccine shows over 91% efficacy in phase 3 trial

Rediff.com2 Feb 2021

The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors -- recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).

Booster dose of anti-Covid vax not needed at this stage: Experts

Booster dose of anti-Covid vax not needed at this stage: Experts

Rediff.com18 Sep 2021

As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.

Chinese Covid vaccine appears safe, induces immune response: Study

Chinese Covid vaccine appears safe, induces immune response: Study

Rediff.com18 Nov 2020

According to the findings of the phase 1/2 randomised clinical trial, published in The Lancet Infectious Diseases journal, the vaccine candidate could induce an antibody response in participants within 28 days of the first immunisation, by giving two doses 14 days apart.

COVID-19: You may need a 'vaccine passport' to fly around the world

COVID-19: You may need a 'vaccine passport' to fly around the world

Rediff.com15 Feb 2021

Several companies and technology heavyweights including Microsoft, Oracle and Salesforce are working to create a digital vaccination passport or health passport app in the hope that governments and airlines will require travellers to upload details of their Covid-19 tests and immunisation. The vaccine passport will effectively create digital credentials that could be the key to attending crowded events or even visiting countries.

Financial crisis could send suicide, homicide rate

Financial crisis could send suicide, homicide rate

Rediff.com8 Jul 2009

Researchers at London School of Hygiene and Tropical Medicine and Oxford University headed the study to examine the possibility that health might suffer as a result of the market crashes. Lead author David Stuckler estimated that increased stress stemming from job losses could prompt a 2.4 per cent rise in suicide rates. Another 2.7 per cent rise in heart attack deaths could be expected, along with a 2.4 per cent increase in homicides rates.

Scientists say Oxford Covid vaccine looks safe, induces immunity

Scientists say Oxford Covid vaccine looks safe, induces immunity

Rediff.com20 Jul 2020

The results show they induced strong antibody and T-cell immune responses for up to 56 days after they were given. T-cells are crucial for maintaining protection against the virus for years.

COVID-19: How The RAT Can Help

COVID-19: How The RAT Can Help

Rediff.com2 Feb 2022

'Serial testing is much more valuable than a single test which reflects just a point in time.'

Coronavirus can last on face masks for a week: Study

Coronavirus can last on face masks for a week: Study

Rediff.com6 Apr 2020

'If you want to protect yourself just maintain good hygiene, wash your hands often and try not to touch your face, your mouth or nose without cleaning first'

Dark chocolate does more harm than good

Dark chocolate does more harm than good

Rediff.com21 Dec 2007

Dark chocolate contained no flavanols but was rich in fat and sugar, both potentially harmful to heart and arteries

India to have 60 pc of world's heart patients

India to have 60 pc of world's heart patients

Rediff.com26 Apr 2008

India is expected to account for 60 per cent of the world's heart disease cases in the world within the next two years, warn researchers. "As the Indian economy grows, there is a possibility of further increases in cardiovascular disease, before we see a decline similar to that being witnessed in developed countries," Lancet quoted United States cardiologist Kim Eagle as saying. Though the risk factors related to heart disease was similar, the access to health care was poor.

Many Indian children under 5 are stunted: study

Many Indian children under 5 are stunted: study

Rediff.com13 May 2008

Nearly 50 pc children under five years of age in India have stunted growth mainly because of zinc, iron and vitamin A deficiencies, according to a new study.

Eat less meat to slow global warming

Eat less meat to slow global warming

Rediff.com13 Sep 2007

The study called for people in wealthy countries to more than halve their daily meat intake -- particularly red meat -- over the next 40 years to stop emission levels from rising further.

'We haven't heard the last about Omicron'

'We haven't heard the last about Omicron'

Rediff.com31 Dec 2021

'Your body will be able to deal with Omicron at any time, but it depends (on when) if you are vaccinated.'